Please Wait.....
Report
North America In-Vitro Diagnostics Market Forecast to 2030 - COVID-19 Impact and Regional Analysis by Product and Services (Reagents and Kits, Instruments, and Software and Services), Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation and Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Home Care, and Others)
Market Report I 2023-07-04 I 201 Pages I The Insight Partners
The North America in-vitro diagnostics market is expected to grow from US$ 56,890.44 million in 2022 to US$ 78,479.05 million by 2028; it is estimated to register a CAGR of 4.1% from 2022 to 2030.
The increasing prevalence of chronic and infectious diseases and rising demand for in-vitro diagnostics during COVID-19 pandemic. However, the cumbersome reimbursement procedures and stringent regulations regarding product approvals hinder the growth of the North America in-vitro diagnostics market.
In-vitro diagnostics can detect diseases or other conditions and can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Devices can range from simple tests to sophisticated DNA technology which include reagents, control materials, calibrators, kits, software, and related instruments. In-vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies.
Integration of IVD Technologies with Digital Health Solutions to offer Lucrative Opportunities
The integration of IVD technologies with digital health solutions is gaining traction in North America. The use of data analytics, artificial intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. The digital health solutions allows IVD technologies to be integrated into clinical decision support system. As recognized by the WHO, digital health solutions could help in disease detection. Key technologies for disease detection are in-vitro diagnostic devices (IVDs). IVDs are used in clinical, laboratory or outpatient settings with the aim specifically to help in the detection of diseases and, as a consequence, in the selection of appropriate treatment protocols. Nowadays, the use of digital technology in healthcare is a way to increase access to diagnostic may improve the quality treatment. Emerging solutions including the use of artificial intelligence, health bots may present opportunities for patient care and address issues of high costs and time consumption. In genomic testing diagnostics, deep learning is be used to identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific cancer. Artificial Intelligence and machine learning for in-vitro diagnostics (AI/ML) is revolutionizing medical device development and is being leveraged in applications ranging from digital image analysis to in-vitro diagnostics. Although it is expected that the number of AI/ML-enabled medical device products will increase exponentially in the future. AI-based IVDs have potential to exponentially improve healthcare decision making in the coming years. The integration and implementation of AI in IVDs has the potential to revolutionize the status quo of assessing disease and health. Smart Diagnostics are extremely scalable IVDs that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, Smart Diagnostics could derive emergent features through unique chemical and biological signature detection and analysis, which has the potential to significantly improve health care. These aspects are likely to offer lucrative opportunities to the market players, which is expected to fuel the growth of the North America in-vitro diagnostics market in the coming years.
Product and Services-Based Insights
Based on products and services, the North America in-vitro diagnostics market is segmented into kits, instruments, software and services. In 2022, the reagents and kits segment accounted for the largest in-vitro diagnostics market share and is anticipated to register a higher CAGR during the forecast period. The major driving factor for the growth of the automated segment is the rise in automated instruments that simplify the job and provide accurate results.
Technology-Based Insights
By technology, the North America in-vitro diagnostics market is categorized into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation and hemostasis, hematology, urinalysis, and others. In 2022, the immunoassay/ immunochemistry segment held the largest share of the market. However, the molecular diagnostics segment is expected to grow at the fastest rate during the coming years owing to the launch of novel products and continuous evolution in technology. Moreover, COVID-19 has positively impacted immunoassay and molecular diagnostics.
Application-Based Insights
By application, the North America in-vitro diagnostics market is segmented into infectious disease, diabetes, oncology, cardiology, autoimmune disease, nephrology, and others. In 2022, the infectious disease segment held the largest share of the market. Moreover, the same segment is expected to register the highest CAGR of 4.6% in the market during the forecast period. The rising prevalence of infectious disease such as SARS-CoV-2, HIV, AIDS, TB, and pneumonia.
End User-Based Insights
Based on end user, the North America in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. In 2022, the hospitals segment held the largest share of the market due to an increase in hospitalizations, which need rapid diagnostics. Additionally, it is projected that the continued expansion of the healthcare infrastructure would improve the current hospital facilities. As a result, there is a rising demand for IVD testing performed in hospitals. However, the homecare segment is expected to grow at the fastest rate during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the North America in-vitro diagnostics market are the company whitepaper (Roche) and World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), among others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America In-Vitro Diagnostics Market - by Product and Services
1.3.2 North America In-Vitro Diagnostics Market - by Technology
1.3.3 North America In-Vitro Diagnostics Market - by Application
1.3.4 North America In-Vitro Diagnostics Market - by End User
1.3.5 North America In-Vitro Diagnostics Market - by Country
2. North America In-Vitro Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Vitro Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 NORTH AMERICA - PEST Analysis
4.3 Expert Opinion
4.4 Regulatory Scenario
4.4.1 FDA IVD Regulation
4.4.2 LDT
4.4.3 RUO
5. In-Vitro Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Rise in the Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraints
5.2.1 Cumbersome Reimbursement Procedures and Stringent Regulations Regarding Product Approvals
5.3 Market Opportunities
5.3.1 Integration of IVD Technologies with Digital Health Solutions
5.4 Impact analysis
6. North America In-Vitro Diagnostics Market Analysis
6.1 North America In-Vitro Diagnostics Market Revenue Forecast and Analysis
6.1.1 Market Positioning of Key Players in In-Vitro Diagnostics Market
7. North America In-Vitro Diagnostics Market Analysis - by Products and Services
7.1 Overview
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
7.4.1 Overview
7.4.2 Software and Services: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. North America In-Vitro Diagnostics Market Analysis - by Technology
8.1 Overview
8.2 Immunoassay/Immunochemistry
8.2.1 Overview
8.2.2 Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Clinical Chemistry
8.3.1 Overview
8.3.2 Clinical Chemistry: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Molecular Diagnostics
8.4.1 Overview
8.4.2 Molecular Diagnostics: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Microbiology
8.5.1 Overview
8.5.2 Microbiology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Blood Glucose Self-Monitoring
8.6.1 Overview
8.6.2 Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Coagulation and Hemostasis
8.7.1 Overview
8.7.2 Coagulation and Hemostasis: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Hematology
8.8.1 Overview
8.8.2 Hematology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Urinalysis
8.9.1 Overview
8.9.2 Urinalysis: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. North America In-Vitro Diagnostics Market Analysis - by Application
9.1 Overview
9.2 Infectious Disease
9.2.1 Overview
9.2.2 Infectious Disease: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Diabetes
9.3.1 Overview
9.3.2 Diabetes: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Autoimmune Disease
9.6.1 Overview
9.6.2 Autoimmune Disease: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Nephrology
9.7.1 Overview
9.7.2 Nephrology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. North America In-Vitro Diagnostics Market Analysis - by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Laboratories
10.3.1 Overview
10.3.2 Laboratories: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Homecare
10.4.1 Overview
10.4.2 Homecare: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. North America In-Vitro Diagnostics Market - Regional Analysis
11.1 North America In-Vitro Diagnostics Market
11.1.1 Overview
11.1.2 North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.6.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.6.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.6.1.5 US: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.6.1.6 US: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.6.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.6.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.6.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.6.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.6.3 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.6.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.6.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.6.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Pre and Post Covid-19 Impact on North America In-Vitro Diagnostics Market
12.1 Pre and Post Covid-19 Impact
13. North America In-Vitro Diagnostics Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies in North America In-Vitro Diagnostics Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Danaher Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Siemens AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sysmex Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Becton Dickinson and Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Qiagen NV
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 2. North America: In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America: In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America: In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. US: In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 6. US: In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. US: In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 8. US: In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada: In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada: In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada: In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico: In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico: In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico: In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Organic Growth Strategies in North America In-Vitro Diagnostics Market
Table 18. Recent Inorganic Growth Strategies in the North America In-Vitro Diagnostics Market
Table 19. Glossary of Terms, North America In-Vitro Diagnostics Market
LIST OF FIGURES
Figure 1. In-Vitro Diagnostics Tube Market Segmentation
Figure 2. In-Vitro Diagnostics Market Segmentation, by Country
Figure 3. North America In-Vitro Diagnostics Market Overview
Figure 4. Reagents and Kits Held Largest Share of Product and Services Segment in In-Vitro Diagnostics Market
Figure 5. North America In-Vitro Diagnostics Market - Leading Country Markets (US$ Million)
Figure 6. North America In-Vitro Diagnostics Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. North America In-Vitro Diagnostics Market - Revenue Forecast and Analysis - 2020-2030
Figure 10. North America In-Vitro Diagnostics Market, by Products and Services, 2022 & 2030 (%)
Figure 11. Reagents and Kits: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Instruments: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Software and Services: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. North America In-Vitro Diagnostics Market, by Technology, 2022 & 2030 (%)
Figure 15. Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Clinical Chemistry: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Molecular Diagnostics: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Microbiology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Coagulation and Hemostasis: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Hematology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Urinalysis: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America In-Vitro Diagnostics Market, by Application, 2022 & 2030 (%)
Figure 25. Infectious Disease: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diabetes: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Oncology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Cardiology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Autoimmune Disease: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Nephrology: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America In-Vitro Diagnostics Market, by Application, 2022 & 2030 (%)
Figure 33. Hospitals: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Laboratories: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Homecare: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. Others: North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 37. North America In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 38. North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 39. North America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 40. US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 41. Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 42. Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. Pre and Post Covid-19 Impact on In-Vitro Diagnostics Market in North America
Figure 44. Growth Strategies in North America In-Vitro Diagnostics Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security